<DOC>
	<DOCNO>NCT00830115</DOCNO>
	<brief_summary>The aim study evaluate effect pantoprazole sleep disorder patient NERD ( non-erosive reflux disease ) eGERD ( erosive gastroesophageal reflux disease ) . The prevalence intensity sleep disorder evaluate standardized questionnaire . The study expect provide data safety tolerability pantoprazole .</brief_summary>
	<brief_title>Pantoprazole 20/40 mg Treatment Symptomatic Reflux Disease With Focus Sleep Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Main inclusion criterion : Outpatients erosive gastroesophageal reflux disease ( eGERD ) nonerosive reflux disease ( NERD ) Main exclusion criterion : Criteria define respective Summary Product Characteristics ( Chapter 4.3 )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>PPI therapy</keyword>
	<keyword>Pantoprazole</keyword>
	<keyword>eGERD ( Erosive Gastroesophageal Reflux Disease )</keyword>
	<keyword>NERD ( Non-Erosive Reflux Disease )</keyword>
</DOC>